July 28, 2005 08:32 ET

Pacific Sunset Investments Inc. Specializing in Ways to Eliminate Adverse Drug Reactions, Announces The IO Circuit

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit.

LAKE HARMONY, PA -- (MARKET WIRE) -- July 28, 2005 -- The IO Circuit recommends Pacific Sunset Investments Inc. ("Pacific Sunset") (OTC BB: PSIV), who specializes in Single Nucleotide Polymorphism ("SNP") analysis data, is revealing their ability to provide physicians with information specific to a patient's genetic profile.

For more information, go to

Other active stocks are Nutrisystem Inc (NASDAQ: NTRI), Digital River, Inc (NASDAQ: DRIV) and Repligen Corp (NASDAQ: RGEN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $545.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information